Transforming Cancer Treatment with Innovative Solutions
At Oncogen Pharma, we are proud to offer a diverse and innovative product portfolio focused on addressing the critical needs of cancer patients. Our commitment to excellence drives us to develop high-quality oncology generics that make a real difference in the lives of those fighting cancer. Explore our range of products below:
OUR PRODUCTS
IMATIGLIV
IMATIGLIV is an oncology drug specifically designed to treat adult and paediatric patients diagnosed with chronic myeloid leukemia (CML) carrying the Philadelphia chromosome mutation (Ph+). With its targeted mechanism of action, IMATIGLIV aims to disrupt the growth of cancer cells, offering new hope for patients and their families.
NILOSIGNA is an oncology drug specifically designed for patients newly diagnosed with Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in the chronic phase. With its targeted approach, NILOSIGNA aims to bring hope and transformation to patients by effectively managing their condition and improving their quality of life.
Abytiga is a specialized oncology medication tailored for individuals diagnosed with Metastatic castration-resistant prostate cancer (mCRPC). Employing a targeted strategy, Abytiga strives to offer optimism and positive change for patients by efficiently addressing their condition and enhancing their overall quality of life.
Pazorene has been intricately formulated to cater to individuals diagnosed with advanced and/or metastatic renal cell carcinoma, as well as those with advanced soft tissue sarcoma who have undergone previous chemotherapy treatments. With its specific therapeutic focus, Pazorene is committed to offering hope and fostering a positive change in the lives of patients.
Pectibine has been meticulously crafted for individuals diagnosed with Colorectal Cancer, Breast Cancer, Gastric, Esophageal, or Gastroesophageal Junction Cancer, as well as Pancreatic Cancer. Through its targeted therapeutic approach, Pectibine is dedicated to instilling hope and bringing about a positive transformation in the lives of patients
